Treatments for alcohol dependence: Rethinking the role of comorbidity and clinical subtypes

American Journal of Psychiatry

Volumn 167, Issue 6, 2010, Pages 620-622

  Patkar, Ashwin A ^a   Li, Ting Kai ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; DISULFIRAM; GAMMA GLUTAMYLTRANSFERASE; NALTREXONE; ONDANSETRON; PLACEBO; SERTRALINE; TOPIRAMATE;

ALCOHOL ABSTINENCE; ALCOHOLISM; CLINICAL TRIAL; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DRUG DOSE TITRATION; EDITORIAL; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC RISK; HUMAN; LOW DRUG DOSE; MONOTHERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ALCOHOLISM; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; HUMANS; NALTREXONE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 77952965290     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2010.10030309     Document Type: Editorial

References (8)

1. Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, Dackis CA, O'Brien CP: A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry 2010; 167:668-675
2. Johnson BA: Medication treatment of different types of alcoholism. Am J Psychiatry 2010; 167:630-639
3. National Institute on Alcohol Abuse and Alcoholism: Helping Patients Who Drink Too Much: A Clinician's Guide. Bethesda, Md, National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 2005
4. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift RM, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group: Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006; 295:2003-2017
5. Bogenschutz MP, Scott Tonigan J, Pettinati HM: Effects of alcoholism typology on response to naltrexone in the COMBINE study. Alcohol Clin Exp Res 2009; 33:10-18
6. Kampman KM, Pettinati HM, Lynch KG, Xie H, Dackis C, Oslin DW, Sparkman T, Sharkoski T, O'Brien CP: Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence. Addict Behav 2009; 34:581-586
7. Mann K, Kiefer F, Smolka M, Gann H, Wellek S, Heinz A; PREDICT Study Research Team: Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. Alcohol Clin Exp Res 2009; 33:674-683
8. American Psychiatric Association: Proposed Draft Revisions to DSM Disorders and Criteria. Arlington, Va, American Psychiatric Association, 2010. http://www.dsm5.org/Pages/Default.aspx